Corona vaccine update: India's Corona vaccine ready, know how long it will launch

Corona vaccine latest news: Indian Council of Medical Research (ICMR) and Hyderabad-based Bharat Biotech International Ltd (BBIL) have developed this vaccine. It is named BBV152 Covid Vaccine.

India has been a big success in the discovery of Coronavirus vaccine. A vaccine made entirely in the country is ready. The clinical trial of this vaccine made in the joint venture of the Indian Council of Medical Research i.e. ICMR and Bharat Biotech International Ltd will be on 'Priority'. A dozen institutes have been selected for the clinical trials of the BBV152 COVID vaccine. According to the ICMR, after all the trials, this vaccine is set to be launched on August 15, the Independence Day. The Indian Council of Medical Research (ICMR) has asked select medical institutions and hospitals to provide indigenous vaccine for Kovid-19 by 15 August for medical use, to develop potential vaccine 'covaxin' in collaboration with Bharat Biotech Speed ​​up the approval to test for.

This vaccine is made from SARS-CoV-2.

This indigenous vaccine is produced from a strain of SARS-CoV-2 isolated by the ICMR-National Institute of Virology.

Where will the clinical trial of vaccine?

12 institutes have been selected for the trial of indigenous Covid vaccine.

These institutes are as follows:

AIIMS, New Delhi

AIIMS, Patna (Bihar)

King George's Hospital, Visakhapatnam (Andhra Pradesh)

Pandit BD Sharma PGIMS, University of Health Sciences, Rohtak (Haryana)

Jeevan Rekha Hospital, Belagavi (Karnataka)

Gillurkar Multispeciality Hospital, Nagpur (Maharashtra)

Rana Hospital and Trauma Center, Gorakhpur (Uttar Pradesh)

SRM Hospital and Research Center, Kattankulathur (Tamil Nadu)

Nizam Institute of Medical Sciences, Hyderabad (Telangana)

Prakhar Hospital, Kanpur (Uttar Pradesh)

Redkar Hospital, Goa

Institute of Medical Sciences and SUM Hospital, Jajpur (Odisha)

Trial results will be important..

Now clinical trials of this vaccine will begin. The institutes selected by ICMR have been told that the final outcome of this vaccine will depend on their cooperation. These institutes have been shown to show a rapid increase in approvals associated with clinical trials.

Little carelessness will be heavy

ICMR has ordered that if institutes are negligent, they will be taken seriously. It has been suggested that the trials should be completed at the highest priority within the stipulated time.

Vaccine making race in all over the world

Corona has infected more than 10 million people worldwide so far. It has already had more than 6 lakh cases in India. Researchers around the world are running a race for vaccination of this deadly virus.

No vaccine approval yet commercially

More than 125 hundred vaccines are being developed worldwide. Some are being tried on humans and some are in the initial trial. There is not a single vaccine yet approved for commercial use for Kovid-19.